199 related articles for article (PubMed ID: 28740407)
1. Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells.
Woitok M; Klose D; Di Fiore S; Richter W; Stein C; Gresch G; Grieger E; Barth S; Fischer R; Kolberg K; Niesen J
Onco Targets Ther; 2017; 10():3313-3327. PubMed ID: 28740407
[TBL] [Abstract][Full Text] [Related]
2. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
[TBL] [Abstract][Full Text] [Related]
3. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
Mungra N; Biteghe FAN; Malindi Z; Huysamen AM; Karaan M; Hardcastle NS; Bunjun R; Chetty S; Naran K; Lang D; Richter W; Hunter R; Barth S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12203-12225. PubMed ID: 37432459
[TBL] [Abstract][Full Text] [Related]
4. Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells.
Huysamen AM; Fadeyi OE; Mayuni G; Dogbey DM; Mungra N; Biteghe FAN; Hardcastle N; Ramamurthy D; Akinrinmade OA; Naran K; Cooper S; Lang D; Richter W; Hunter R; Barth S
ACS Omega; 2023 Jan; 8(4):4026-4037. PubMed ID: 36743041
[TBL] [Abstract][Full Text] [Related]
5. EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment.
Zhang C; Sheng W; Al-Rawe M; Mohiuddin TM; Niebert M; Zeppernick F; Meihold-Heerlein I; Hussain AF
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682800
[TBL] [Abstract][Full Text] [Related]
6. SNAP-Tag Technology: A Useful Tool To Determine Affinity Constants and Other Functional Parameters of Novel Antibody Fragments.
Niesen J; Sack M; Seidel M; Fendel R; Barth S; Fischer R; Stein C
Bioconjug Chem; 2016 Aug; 27(8):1931-41. PubMed ID: 27391930
[TBL] [Abstract][Full Text] [Related]
7. One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology.
Hussain AF; Heppenstall PA; Kampmeier F; Meinhold-Heerlein I; Barth S
Nat Protoc; 2019 Nov; 14(11):3101-3125. PubMed ID: 31605098
[TBL] [Abstract][Full Text] [Related]
8. Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer.
Padayachee ER; Biteghe FAN; Malindi Z; Bauerschlag D; Barth S
Transfus Med Hemother; 2017 Sep; 44(5):303-310. PubMed ID: 29070975
[TBL] [Abstract][Full Text] [Related]
9. Applications of SNAP-tag technology in skin cancer therapy.
Padayachee ER; Adeola HA; Van Wyk JC; Nsole Biteghe FA; Chetty S; Khumalo NP; Barth S
Health Sci Rep; 2019 Feb; 2(2):e103. PubMed ID: 30809593
[TBL] [Abstract][Full Text] [Related]
10. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein.
Kampmeier F; Niesen J; Koers A; Ribbert M; Brecht A; Fischer R; Kiessling F; Barth S; Thepen T
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1926-34. PubMed ID: 20449589
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
[TBL] [Abstract][Full Text] [Related]
12. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.
Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S
Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499
[TBL] [Abstract][Full Text] [Related]
13. Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy.
Li Z; Wang M; Yao X; Luo W; Qu Y; Yu D; Li X; Fang J; Huang C
Target Oncol; 2019 Feb; 14(1):93-105. PubMed ID: 30635821
[TBL] [Abstract][Full Text] [Related]
14. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N
Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511
[TBL] [Abstract][Full Text] [Related]
15. Detection and Specific Elimination of EGFR
Bauerschlag D; Meinhold-Heerlein I; Maass N; Bleilevens A; Bräutigam K; Al Rawashdeh W; Di Fiore S; Haugg AM; Gremse F; Steitz J; Fischer R; Stickeler E; Barth S; Hussain AF
Pharm Res; 2017 Apr; 34(4):696-703. PubMed ID: 28074431
[TBL] [Abstract][Full Text] [Related]
16. SNAP-tag based agents for preclinical in vitro imaging in malignant diseases.
Amoury M; Blume T; Brehm H; Niesen J; Tenhaef N; Barth S; Gattenlöhner S; Helfrich W; Fitting J; Nachreiner T; Pardo A
Curr Pharm Des; 2013; 19(30):5429-36. PubMed ID: 23431985
[TBL] [Abstract][Full Text] [Related]
17. Targeting and Covalently Immobilizing the EGFR through SNAP-Tag Technology for Screening Drug Leads.
Fu J; Jia Q; Liang P; Wang S; Zhou H; Zhang L; Gao C; Wang H; Lv Y; Han S
Anal Chem; 2021 Aug; 93(34):11719-11728. PubMed ID: 34415741
[TBL] [Abstract][Full Text] [Related]
18. Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.
Chouman K; Woitok M; Mladenov R; Kessler C; Weinhold E; Hanz G; Fischer R; Meinhold-Heerlein I; Bleilevens A; Gresch G; Haugg AM; Zeppernick F; Bauerschlag D; Maass N; Stickeler E; Kolberg K; Hussain AF
Anticancer Agents Med Chem; 2017; 17(10):1434-1440. PubMed ID: 28270070
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP
J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth.
Hussain AF; Krüger HR; Kampmeier F; Weissbach T; Licha K; Kratz F; Haag R; Calderón M; Barth S
Biomacromolecules; 2013 Aug; 14(8):2510-20. PubMed ID: 23782069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
